Core Viewpoint - Redwire stock has experienced significant gains over the past year, but current market conditions suggest it may be time to sell despite winning a NASA contract for a space biotechnology experiment [1][6]. Company Summary - Redwire has secured a NASA contract to facilitate a Space Microalgae biotechnology experiment, which will be conducted aboard the upcoming Axiom Mission 4 to the International Space Station [1][4]. - The experiment aims to analyze the growth, metabolism, and genetic activity of three strains of edible microalgae, potentially serving as a sustainable food source for long-duration space missions [4]. Financial Performance - Redwire's stock has more than tripled in price over the past year, currently valued at $1.5 billion, but the company has no profits and less than $280 million in revenue [6]. - The stock carries a price-to-sales ratio of over 5.3, which is significantly higher than the estimated range of 2 to 4 times trailing sales for profitless space stocks [6][7]. - A year ago, Redwire stock was valued at only 1.4 times sales, indicating a substantial increase in valuation [6].